Sommetrics,
a company providing products and services to improve sleep quality,
today announced it has been selected to be one of five companies to
present at the airways symposium of the Respiratory Innovation Summit in
Dallas on May 17, 2019. This Summit is a yearly event held in advance of
the American Thoracic Society’s International meeting which brings
together clinicians, innovators and investors focused on new approaches
for treating widespread and crippling lung and airway diseases.
“This is an ideal venue for highlighting the clinical progress made in
establishing our aerSleep™ system as a treatment option for obstructive
sleep apnea (OSA),” remarked Dr. Richard Rose, President, CEO and Chief
Medical Officer of Sommetrics. ”It is particularly appropriate to
discuss aerSleep™ in the context of airways disease since OSA is now
believed to be the commonest chronic respiratory disorder worldwide –
more prevalent than asthma or COPD. Yet, only a small fraction of
individuals with OSA are currently receiving effective therapy. It is
this extraordinary medical need that our aerSleep™ system addresses.”
The aerSleep™ system consists of a comfortable silicone collar fitted on
the front of the neck which holds the airway open via the application of
mild external negative pressure delivered by a quiet, integrated vacuum
pump. This system has a number of advantages over conventional sleep
apnea therapies in that it is non-invasive, simple to use and maintain,
highly portable and well tolerated by the majority of users. An earlier
version of aerSleep has previously received market clearance from Health
Canada.
About Sommetrics
Sommetrics is a privately funded company located in San Diego,
California. It is focused on improving sleep quality by providing
products and services that deal with disorders of the upper airway such
as obstructive
sleep apnea (OSA) and snoring. For more information, visit www.sommetrics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005963/en/